Hormone replacement therapy and Lipoprotein (a) plasma levels in women in reproductive age with hysterectomy and bilateral oophorectomy

Italian Journal of Gynaecology and Obstetrics

Volumn 14, Issue 1-2, 2002, Pages 27-30

  Azzena, A ^a   Rulli, R ^a   Bernardi, C ^a   Zannoli, M ^a   Zen, T ^a   Cardascia, L ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Cardiovascular disease; Hormone replacement therapy; Lipoprotein (a); Menopause

Indexed keywords

ESTRADIOL; ETHINYLESTRADIOL; FOLLITROPIN; LIPID; LIPOPROTEIN A; LUTEINIZING HORMONE; PRASTERONE SULFATE; PROGESTERONE; SEX HORMONE; TESTOSTERONE;

ADULT; AGE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; FEMALE; FERTILITY; FOLLITROPIN BLOOD LEVEL; HEART RATE; HORMONE DETERMINATION; HORMONE SUBSTITUTION; HUMAN; HYSTERECTOMY; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; LUTEINIZING HORMONE BLOOD LEVEL; MENOPAUSAL SYNDROME; OVARIECTOMY; PREMENOPAUSE; PROGESTERONE BLOOD LEVEL; REPRODUCTIVE HEALTH; RISK FACTOR; TESTOSTERONE BLOOD LEVEL;

EID: 0036433339     PISSN: 11218339     EISSN: 23850868     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Lipoprotein(a). Lancet 1991; 337: 397-8; Editorial.
2. Scanu AM, Gunther MF. Lipoprotein(a). J Clin Invest 1990; 85: 1709-15.
3. Loscalzo J. Lipoprotein(a): a unique risk factor for artherothrombotic disease. Artherosclerosis 1990;10: 672-9.
4. Scott J. Lipoprotein(a). BMJ 1991;33: 663-4.
5. Miles LA, Fless GM, Levin EG, et al. A potential basis for the thrombotic risk associated with lipoprotein(a). Nature 1989; 339: 301-5.
6. Heofler G, Harnoncourt F, Paschke E, et al. Lipoprotein(a) a risk factor for myocardial infarction. Artherosclerosis 1988; 8: 398-401.
7. Lp(a) joins other serum cholesterol lipoproteins as risk determinant. JAMA 1989; 261: 2013-14.
8. Dahlen GH, Guyton JR, Farmer JA, et al. Association of level of Lipoprotein(a), plasma lipids and other lipoproteins with coronary artery disease documented by angiography. Circulation 1986; 74: 758-65.
9. Carlson LA, Hamsten A, Asplund A. A pronounced lowering of serum levels of lipoprotein(a) in hyperlipidemic subjects treated with nicotinic acid. J Inter Med 1989; 226: 271-6.
10. Illinworth DR, Stein EA, Mitchell YB. Comparative effects of lovastatin and niacin in primary hypercholesterolemia: a prospective trial. Arch Intern Med 1994; 154: 1586-95.
11. Kalim M, Zumorf B. Sex hormones and coronary disease: a review of clinical studies. Steroids 1990; 55: 330-52.
12. National Institute of Health. Chartbook on cardiovascular, lung and blood disease. Washington DC, USA, Department of Health and Human Services, 1992.
13. Bengtsson C. Ischaemic heart disease on randomized population sample of women with myocardial infarction in Goteberg, Sweden. Acta Med Scand 1973; 5: 1-128.
14. Heiss G, Tamir I, Davis C. Lipoprotein cholesterol distribution in selected North American population: the lipid research clinic program prevalence study Circulation 1980; 61: 302-14.
15. Chee Jeong K, Hak Cul J, Dong Hee C, et al. Effects of hormone replacement therapy on lipoprotein(a) and lipids in postmenopausal women. Ater and Tromb 1994; 14(2): 275-81.
16. Soma M, Osnago Gadda I, Paoletti R, et al. The lowering of lipoprotein(a) induced by estrogen plus progesterone replacement therapy in postmenopausal women. Arch Intern Med 1993; 153: 1462-8.
17. Nabulsi A, Folsom A, White A, et al. Association of hormone replacement therapy with various cardiovascular risk factors in postmenopausal women. N E J Med 1993; 328(15): 1069-75.
18. Mendoza S, Velasquez E, Osona T. Postmenopausal cyclic estrogen progestin therapy lowers lipoprotein(a). J Lab Clin Med 1994; 123(6): 837-41.
19. Lobo RA. Effects of hormone replacement therapy on lipids and lipoprotein in postmenopausal women. I Clin Endocrinol Metab 1991; 73: 925-93.
20. Farish E, Fletcher CD, Hart DM, et al. Lipoprotein and apoprotein levels in postmenopausal women during treatment with noretisterone. Clin Chim Acta 1986; 159: 147-51.
21. Haines C, Chung T, Chang A, et al. Effects of oral estradiol on Lp(a) and others lipoproteins in postmenopausal women. Arch Intern Med 1996; 156: 866-72.